ArticleVaccines2023

Stimulation of Potent Humoral and Cellular Immunity via Synthetic Dual-Antigen MVA-Based COVID-19 Vaccine COH04S1 in Cancer Patients Post Hematopoietic Cell Transplantation and Cellular Therapy.

Flavia Chiuppesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.